Illumina, Inc. (ILMN)
NASDAQ: ILMN · IEX Real-Time Price · USD
105.51
+0.01 (0.01%)
At close: Jul 2, 2024, 4:00 PM
107.49
+1.98 (1.88%)
After-hours: Jul 2, 2024, 7:46 PM EDT
Illumina Revenue
Illumina had revenue of $4.49B in the twelve months ending March 31, 2024, with 1.03% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.08B, a -1.01% decrease year-over-year. In the year 2023, Illumina had annual revenue of $4.50B, a decrease of -1.75%.
Revenue (ttm)
$4.49B
Revenue Growth
+1.03%
P/S Ratio
3.74
Revenue / Employee
$336,302
Employees
13,360
Market Cap
16.81B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
Jan 3, 2021 | 3.24B | -304.00M | -8.58% |
Dec 29, 2019 | 3.54B | 210.00M | 6.30% |
Dec 30, 2018 | 3.33B | 581.00M | 21.11% |
Dec 31, 2017 | 2.75B | 354.00M | 14.76% |
Jan 1, 2017 | 2.40B | 178.00M | 8.02% |
Jan 3, 2016 | 2.22B | 358.64M | 19.27% |
Dec 28, 2014 | 1.86B | 440.18M | 30.97% |
Dec 29, 2013 | 1.42B | 272.66M | 23.74% |
Dec 30, 2012 | 1.15B | 92.98M | 8.81% |
Jan 1, 2012 | 1.06B | 152.79M | 16.93% |
Jan 2, 2011 | 902.74M | 236.42M | 35.48% |
Jan 3, 2010 | 666.32M | 93.10M | 16.24% |
Dec 28, 2008 | 573.23M | 206.43M | 56.28% |
Dec 30, 2007 | 366.80M | 182.21M | 98.71% |
Dec 31, 2006 | 184.59M | 111.09M | 151.13% |
Jan 1, 2006 | 73.50M | 22.92M | 45.31% |
Jan 2, 2005 | 50.58M | 22.55M | 80.43% |
Dec 28, 2003 | 28.04M | 18.00M | 179.23% |
Dec 29, 2002 | 10.04M | 7.55M | 303.86% |
Dec 30, 2001 | 2.49M | 1.18M | 89.92% |
Dec 31, 2000 | 1.31M | 835.00K | 176.16% |
Dec 31, 1999 | 474.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Molina Healthcare | 35.85B |
Baxter International | 14.89B |
Labcorp Holdings | 12.30B |
Quest Diagnostics | 9.29B |
Hologic | 3.96B |
The Cooper Companies | 3.73B |
Waters | 2.91B |
BeiGene | 2.76B |
ILMN News
- 4 days ago - Illumina Takes a $1.47 Billion Charge Related to Its Spinoff of GRAIL - Investopedia
- 5 days ago - Illumina to take $1.47 bln goodwill impairment charge related to Grail in Q2 - Reuters
- 6 days ago - Illumina Completes Spin-Off Of GRAIL - Forbes
- 8 days ago - Grail bets big on flagship cancer test after spin-off from Illumina - Reuters
- 8 days ago - Illumina completes the divestiture of GRAIL - PRNewsWire
- 21 days ago - Illumina To Spin-Off GRAIL Unit On June 24 - Forbes
- 21 days ago - Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations - PRNewsWire
- 22 days ago - Illumina Inc. (ILMN): 2024 Company Profile, Product Pipeline Analysis, and Ongoing Clinical Trials Insights - GlobeNewsWire